Henry Schein Stock News

Related Stocks: CGW , SSO , VRNA , ORTX , SHE , PDD , JD , BABA , PRVB , PSTX , TAN , FNV , NEM , CVS , GOLD , HSIC ,

MELVILLE, N.Y.--(BUSINESS WIRE)--The Henry Schein Cares Foundation, in partnership with the UPS Foundation, today announced the third phase of the Wearing is Caring public health campaign, focused on promoting health equity to advance education about, and access to, the COVID-19 vaccines. The campaign was first launched in October 2020 with a primary focus on promoting access to health care among underserved communities, and to encourage mask-wearing as an effective measure to help reduce the

HSIC vs. CNMD: Which Stock Is the Better Value Option?

Henry Schein, Inc. (HSIC) CEO Stanley Bergman on Q3 2021 Results - Earnings Call Transcript

Strengthening demand in the global dental and medical markets drove Henry Schein's (HSIC) revenues in the third quarter.

With the pandemic raging on, testing, vaccine and therapeutic makers are witnessing huge market adoption of their COVID-related support products in Q3.

Henry Schein (HSIC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Amid concerns surrounding growing COVID-19 cases affecting the medical products companies' legacy business, we are optimistic about IDXX, HSIC, CGC and PODD's results this time around.

Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to present at Credit Suisse virtual health care conference on November 9, 2021.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to webcast third quarter 2021 conference call on November 2, 2021.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein CEO Stanley Bergman issues statement supporting primary-care physicians access to COVID-19 vaccines.

This firm overcame a decline in dental services and supply chain challenges to take market share in 2020. Henry Schein's high-touch business adds considerable value to smaller dental and medical opera

Despite its larger presence in a market projected for continued growth, Henry Schein's current valuation implies profits will never surpass 2019 levels.